we have applied the espvr to the assessment of the inotropic effect of the new dihydropyridine calcium channel blocker , nicardipine , in 15 patients with heart failure caused by systolic dysfunction .
C2945601
dihydropyridine calcium channel blocker
C0028005
nicardipine